Skip to main content

and
  1. Article

    Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

    Yu-Hwa Huang, Chen Zhu, Yasuyuki Kondo, Ana C. Anderson, Amit Gandhi in Nature (2024)

  2. No Access

    Article

    Latent human herpesvirus 6 is reactivated in CAR T cells

    Cell therapies have yielded durable clinical benefits for patients with cancer, but the risks associated with the development of therapies from manipulated human cells are understudied. For example, we lack a ...

    Caleb A. Lareau, Yajie Yin, Katie Maurer, Katalin D. Sandor, Bence Daniel in Nature (2023)

  3. Article

    Open Access

    Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma

    Charlotte Elizabeth Graham, Agnieszka Jozwik, Ruby Quartey-Papafio in Leukemia (2021)

  4. Article

    Open Access

    A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies

    CAR T-cell therapies hold great promise for treating a range of malignancies but are however challenged by the complexity of their production and by the adverse events related to their activity. Here we report...

    Julien Valton, Valerie Guyot, Bijan Boldajipour, Cesar Sommer in Scientific Reports (2018)

  5. No Access

    Article

    Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1

    The activating NK cell receptor KIR3DS1 has been linked to the outcome of various human diseases, yet a ligand that would account for its biological effects has remained unknown. Altfeld and colleagues establi...

    Wilfredo F Garcia-Beltran, Angelique Hölzemer, Gloria Martrus in Nature Immunology (2016)

  6. Article

    Correction: Corrigendum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

    Nature 517, 386–390 (2015); doi:10.1038/nature13848 In this Letter, we published the crystal structure of a heterodimer of the human (h)CEACAM1 IgV domain and hTIM-3 IgV domain (Protein Data Bank (PDB) accessi...

    Yu-Hwa Huang, Chen Zhu, Yasuyuki Kondo, Ana C. Anderson, Amit Gandhi in Nature (2016)

  7. Article

    Open Access

    Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation

    Fingolimod (FTY720), the first oral treatment for multiple sclerosis (MS), blocks immune cell trafficking and prevents disease relapses by downregulation of sphingosine-1-phosphate receptor. We determined the ...

    Maria Antonietta Mazzola, Radhika Raheja, Gopal Murugaiyan in Journal of Neuroinflammation (2015)

  8. Article

    Correction: Corrigendum: An IL-27/NFIL3 signalling axis drives Tim-3 and IL–10 expression and T-cell dysfunction

    Nature Communications 6, Article number: 6072 (2015); Published 23 January 2015; Updated 8 July 2015 In the Discussion section of this Article, we inadvertently stated that ‘endogenous IL-27 signalling results...

    Chen Zhu, Kaori Sakuishi, Sheng **ao, Zhiyi Sun, Sarah Zaghouani in Nature Communications (2015)

  9. No Access

    Article

    An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction

    The inhibitory receptor T-cell immunoglobulin and mucin domain-3 (Tim-3) has emerged as a critical regulator of the T-cell dysfunction that develops in chronic viral infections and cancers. However, little is ...

    Chen Zhu, Kaori Sakuishi, Sheng **ao, Zhiyi Sun, Sarah Zaghouani in Nature Communications (2015)

  10. No Access

    Article

    CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

    CEACAM1 functions as a novel heterophilic ligand for TIM-3 and is necessary for TIM-3-mediated tolerance, which has marked consequences for inflammation, infection and cancer.

    Yu-Hwa Huang, Chen Zhu, Yasuyuki Kondo, Ana C. Anderson, Amit Gandhi in Nature (2015)

  11. Article

    Open Access

    Lv4, an activity that restricts nuclear entry of SIVMAC/SIVSM in human blood cells

    Massimo Pizzato, Martha Neagu, Thomas Pertel, Claudia Firrito in Retrovirology (2013)

  12. Article

    IFITM3 restricts the morbidity and mortality associated with influenza

    Interferon-inducible transmembrane (IFITM) protein 3 is shown to be an innate defence mechanism against viral infection in vivo; furthermore, a subset of the patients hospitalized during the H1N1 2009 pandemic ca...

    Aaron R. Everitt, Simon Clare, Thomas Pertel, Sinu P. John, Rachael S. Wash in Nature (2012)

  13. Article

    Open Access

    Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon

    Vpx is a virion-associated protein encoded by SIVSM, a lentivirus endemic to the West African sooty mangabey (Cercocebus atys). HIV-2 and SIVMAC, zoonoses resulting from SIVSM transmission to humans or Asian rhes...

    Thomas Pertel, Christian Reinhard, Jeremy Luban in Retrovirology (2011)

  14. No Access

    Article

    TRIM5 is an innate immune sensor for the retrovirus capsid lattice

    TRIM5 is an E3 ubiquitin ligase with known antiretroviral restriction factor activity, although the mechanisms involved are poorly understood. Luban and colleagues now demonstrate that TRIM5 activates innate i...

    Thomas Pertel, Stéphane Hausmann, Damien Morger, Sara Züger, Jessica Guerra in Nature (2011)

  15. Article

    Open Access

    TRIM5alpha contributes to the anti-viral state

    Thomas Pertel, Martha R Neagu, Stephane Hausman, Madeleine Zufferey in Retrovirology (2009)

  16. No Access

    Article

    Growth Inhibitory Activity of Extracts and Purified Components of Black Cohosh on Human Breast Cancer Cells

    The purpose of this study was to determine whether black cohosh contains constituents that inhibit the growth of human breast cancer cells, and therefore might eventually be useful in the prevention or treatme...

    Linda Saxe Einbond, Masahito Shimizu, Danhua **ao in Breast Cancer Research and Treatment (2004)